The estimated Net Worth of Cuong V Do is at least $1.34 Thousand dollars as of 22 June 2011. Cuong Do owns over 11,210 units of BioVie stock worth over $1,342 and over the last 10 years Cuong sold BIVI stock worth over $0.
Cuong Do BIVI stock SEC Form 4 insider trading
Cuong has made over 3 trades of the BioVie stock since 2010, according to the Form 4 filled with the SEC. Most recently Cuong exercised 11,210 units of BIVI stock worth $729 on 22 June 2011.
The largest trade Cuong’s ever made was exercising 11,210 units of BioVie stock on 22 June 2011 worth over $729. On average, Cuong trades about 1,329 units every 19 days since 2009. As of 22 June 2011 Cuong still owns at least 20,642 units of BioVie stock.
You can see the complete history of Cuong Do stock trades at the bottom of the page.
What’s Cuong Do’s mailing address?
Cuong’s mailing address filed with the SEC is C/O BIOVIE INC., 100 CUMMINGS CENTER SUITE 247C, BEVERLY, MA, 01915.
What does BioVie do?
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which is in Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.
What does BioVie’s logo look like?
Complete history of Cuong Do stock trades at Merck & Co, TE Connectivity, and BioVie
BioVie executives and stock owners
BioVie executives and other stock owners filed with the SEC include:
- Mina Sooch, Independent Director
- Michael Sherman, Independent Director
- James Lang, Independent Director
- Hari Kumar, Independent Director
- Rajah Menon, Director
- Richard Berman, Director
- Patrick Yeramian, Chief Medical Officer
- Penelope Markham, Chief Scientific Officer
- J. Wendy Kim, Chief Financial Officer, Corporate Secretary
- Terren Peizer, Chief Executive Officer, Director
- Jonathan Adams, President, Chief Operating Officer, Director
- Cuong V Do, Director
- R Richard Wieland, interim CFO
- Julie G Anderson, Director
